{"organizations": [], "uuid": "67d66d54d13a1ffb5c13dbf8c8a4e26d7c055ea7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180425.html", "section_title": "Archive News &amp; Video for Wednesday, 25 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-cadila-healthcare-says-zydus-gets/brief-cadila-healthcare-says-zydus-gets-u-s-fda-final-nod-for-methylprednisolone-tablets-usp-cinacalcet-hydrochloride-tablets-idUSFWN1S20Y1", "country": "US", "domain_rank": 408, "title": "BRIEF-Cadila Healthcare Says Zydus Gets U.S. FDA Final Nod For Methylprednisolone Tablets USP, Cinacalcet Hydrochloride Tablets", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-04-25T20:19:00.000+03:00", "replies_count": 0, "uuid": "67d66d54d13a1ffb5c13dbf8c8a4e26d7c055ea7"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-cadila-healthcare-says-zydus-gets/brief-cadila-healthcare-says-zydus-gets-u-s-fda-final-nod-for-methylprednisolone-tablets-usp-cinacalcet-hydrochloride-tablets-idUSFWN1S20Y1", "ord_in_thread": 0, "title": "BRIEF-Cadila Healthcare Says Zydus Gets U.S. FDA Final Nod For Methylprednisolone Tablets USP, Cinacalcet Hydrochloride Tablets", "locations": [], "entities": {"persons": [{"name": "zydus", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-cadila healthcare says zydus gets u.s. fda", "sentiment": "negative"}, {"name": "cadila healthcare ltd", "sentiment": "negative"}, {"name": "methylprednisolone tablets usp", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 25 (Reuters) - Cadila Healthcare Ltd:\n* SAYS ZYDUS GETS FINAL APPROVAL FROM USFDA FOR METHYLPREDNISOLONE TABLETS USP AND CINACALCET HYDROCHLORIDE TABLETS Source text - bit.ly/2Hry5Yw Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "http://bit.ly/2Hry5Yw", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-25T20:19:00.000+03:00", "crawled": "2018-04-26T20:52:54.034+03:00", "highlightTitle": ""}